Abstract
Academic researchers and practicing managers in the area of management of technology are faced with a difficult challenge in attempting to measure technological capability at the firm level. A number of different indicators of firm technological capability (FTC) have been proposed and used, however, they have not been systematically evaluated across different industry settings. These indicators include R&D expenditures, patent statistics, and statistics on new product introductions. In this study, the authors discuss some of the relative advantages and disadvantages of these indicators and they assess their validity in the chemical, electronics and pharmaceutical industries. They find that measures of the scale of FTC are relatively consistent across industries, but that measures of the quality of FTC are somewhat less consistent. Finally, they find limited evidence that aspects of FTC quality are related to firm performance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
